Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia

Journal of the National Cancer Institute

Volumn 87, Issue 18, 1995, Pages 1365-1371

  Ho, Gloria Y F ^a   Burk, Robert D ^a   Klein, Sara ^a   Kadish, Anna S ^a   Chang, C J ^a   Palan, Prabhudas ^a   Basu, Jayasri ^a   Tachezy, Ruth ^a   Lewis, Renee ^a   Romney, Seymour ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; COLPOSCOPY; FEMALE; GENITAL TRACT INFECTION; HUMAN; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; RISK FACTOR; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DYSPLASIA; VIRUS CONCENTRATION; VIRUS TYPING; WART VIRUS;

ADULT; BLOTTING, SOUTHERN; CERVIX DYSPLASIA; DNA, VIRAL; FEMALE; HUMAN; ODDS RATIO; PAPILLOMAVIRUS, HUMAN; PAPOVAVIRIDAE INFECTIONS; POLYMERASE CHAIN REACTION; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR VIRUS INFECTIONS;

EID: 0029147763     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/87.18.1365     Document Type: Article

References (28)

1. Richart RM, Barron BA. A follow-up study of paiients with cervical dysplasia. Am J Obstet Gynecol 1969; 105:386-93.
2. Nasiell K, Nasiell M, Vaclavinkova V. Behavior of moderate cervical dysplasia during long-term follow-up. Obstet Gynecol 1983;61:609-14.
3. Nasiell K, Roger V, Nasiell M. Behavior of mild cervical dysplasia during long-term follow-up. Obstet Gynecol 1986;67:665-9.
4. Syrjanen K, Kataja V, Yliskoski M, Chang F, Syrjanen S, Saarikoski S. Natural history of cervical human papillomavirus lesions does not substantiate the biologic relevance of the Bethesda System. Obstet Gynecol1992;79:675-82.
5. Fox CH. Biologic behavior of dysplasia and carcinoma in situ. Am J Obstet Gynecol 1967;99:960-74.
6. Hall JE, Walton L. Dysplasia of the cervix: a prospective study of 206 cases. Am J Obstet Gynecol 1968; 100:662-71.
7. Santa UV. Diagnosis and prognosis of cervical dysplasia. Obstet Gynecol1971;38:811-6.
8. Sedlis A, Cohen A, Sail S. The fate of cervical dysplasia. Am J Obstet Gynecol 1970;107:1065-70.
9. Koutsky LA. Holmes KK, Critchlow CW, Stevens CE, Paavonen J, Beckmann AM, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992;327:1272-8.
10. Morrison EA, Ho GY, Vermund SH, Goldberg GL, Kadish AS, Kelley KF, et al. Human papillomavirus infection and other risk factors for cervical neoplasia: a case-control study [see comment citation in MedlineJ. Int J Cancer 1991;49:6-13.
11. Negrini BP, Schiffman MH, Kurman RJ, Barnes W, Lannom L, Malley K, et al. Oral contraceptive use. human papillomavirus infection, and risk of early cytological abnormalities of the cervix. Cancer Res 1990:50:4670-5.
12. Syrjanen K, Mantyjarvi R. Parkkinen S. Väyrynen M, Saarikoski S, Syrjanen S, et al. Prospective follow-up in assessment of the biological behavior of cervical HPV-associated dysplastic lesions. In: Banbury Report21: Viral etiology of cervical cancer. Cold Spring Harbor. NY: Cold Spring Harbor Laboratory. 1986: 167-77.
13. Campion MJ, McCance DJ, Cuzick J, Singer A. Progressive potential of mild cervical atypia: prospective cytological, colposcopic, and virological study. Lancet 1986;2:237-40.
14. Burk RD. Kadish AS, Calderin S, Romney SL. Human papillomavirus infection of the cervix detected by cervicovaginal lavage and molecular hybridization: correlation with biopsy results and Papanicolaou smear. Am J Obstet Gynecol 1986;154:982-9.
15. The 1988 Bethesda System for reporting cervical/vaginal cytological diagnoses. National Cancer Institute Workshop. JAMA 1989;262:931-4.
16. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM. The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Ceils 1989;7:209-14.
17. Tachezy R, Van Ranst MA, Cruz Y, Burk RD. Analysis of short novel human papillomavirus sequences. Biochem Biophys Res Commun 1994; 204:820-7.
18. Hildesheim A, Schiffman MH, Gravitt PE. Glass AG, Greer CE, Zhang T. et al. Persistence of type-specific human papillomavirus infection among cytologically normal women [see comment citation in Medline]. J Infect Dis 1994;169:235-40.
19. Van Ranst MA, Tachezy R, Delius H, Burk RD. Taxonomy of the human papillomaviruses. Papillomavirus Rep 1993;4:61-5.
20. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes, Biometrics 1986;42:121-30.
21. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
22. Morrison EA, Burk RD. Classification of human papillomavirus infection [letter], JAMA 1993:270:453.
23. Bauer HM, Ting Y, Greer CE, Chambers JC, Tashiro CJ, Chimera J, et al.Genital human papillomavirus infection in female university students as determined by a PCR-based method [see comment citation in Medline]. JAMA 1991;265:472-7.
24. Moscicki AB, Palefsky JM, Gonzales J, Smith G, Colpo-scopic and histologic findings and human papillomavirus (HPV) DNA test variability in young women positive for HPV DNA. J Infect Dis1992;166:951-7.
25. Kataja V, Syrjanen K, Syrjanen S, Mantyjarvi R, Yliskoski M, Saarikoski S, et al. Prospective follow-up of genital HPV infections; survival analysis- oftheHPVtypingdata.EurJEpidemioT 1990;6:9-14.
26. Parazzini F, La Vecchia C, Negri E, Fedele L, Franceschi S, Gallotta L. Risk factors for cervical intraepithelial neoplasia. Cancer 1992;69:2276-82.
27. Clarke AE, Hatcher J, McKeown-Eyssen GE, Lickrish GM. Cervical dysplasia: association with sexual behavior, smoking, and oral contraceptive use? Am J Obstet Gynecol 1985;151:612-6.
28. Gram IT, Austin H, Stalsberg H. Cigarette smoking and the incidence of cervical intraepithelial neoplasia, grade III, and cancer of the cervix uteri. Am J Epidemiol 1992;135:341-6.